Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vedolizumab for the Treatment of Chronic Pouchitis.
Travis S, Silverberg MS, Danese S, Gionchetti P, Löwenberg M, Jairath V, Feagan BG, Bressler B, Ferrante M, Hart A, Lindner D, Escher A, Jones S, Shen B; EARNEST Study Group. Travis S, et al. Among authors: gionchetti p. N Engl J Med. 2023 Mar 30;388(13):1191-1200. doi: 10.1056/NEJMoa2208450. N Engl J Med. 2023. PMID: 36988594 Clinical Trial.
Clinical guidelines for the management of pouchitis.
Pardi DS, D'Haens G, Shen B, Campbell S, Gionchetti P. Pardi DS, et al. Among authors: gionchetti p. Inflamm Bowel Dis. 2009 Sep;15(9):1424-31. doi: 10.1002/ibd.21039. Inflamm Bowel Dis. 2009. PMID: 19685489
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, Plevy S, Popp J, Cornillie FJ, Lukas M, Danese S, Gionchetti P, Hanauer SB, Reinisch W, Sandborn WJ, Sorrentino D, Rutgeerts P; PREVENT Study Group. Regueiro M, et al. Among authors: gionchetti p. Gastroenterology. 2016 Jun;150(7):1568-1578. doi: 10.1053/j.gastro.2016.02.072. Epub 2016 Mar 3. Gastroenterology. 2016. PMID: 26946343 Free article. Clinical Trial.
Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370].
Armuzzi A, Gionchetti P, Daperno M, Danese S, Orlando A, Scribano ML, Vecchi M, Rizzello F; GIVI (Gruppo Italiano su Vedolizumab nelle IBD) Group. Armuzzi A, et al. Among authors: gionchetti p. Dig Liver Dis. 2016 Sep;48(9):1103. doi: 10.1016/j.dld.2016.06.015. Dig Liver Dis. 2016. PMID: 27555348 No abstract available.
Ustekinumab in the management of Crohn's disease: Expert opinion.
Armuzzi A, Ardizzone S, Biancone L, Castiglione F, Danese S, Gionchetti P, Orlando A, Rizzello F, Scribano ML, Vecchi M, Daperno M. Armuzzi A, et al. Among authors: gionchetti p. Dig Liver Dis. 2018 Jul;50(7):653-660. doi: 10.1016/j.dld.2018.02.017. Epub 2018 Mar 11. Dig Liver Dis. 2018. PMID: 29610019 Review.
Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis.
Samaan MA, Shen B, Mosli MH, Zou G, Sandborn WJ, Shackelton LM, Nelson S, Stitt L, Bloom S, Pardi DS, Gionchetti P, Lindsay J, Travis S, Hart A, Silverberg MS, Feagan BG, D'Haens GR, Jairath V. Samaan MA, et al. Among authors: gionchetti p. Gastrointest Endosc. 2018 Aug;88(2):360-369.e2. doi: 10.1016/j.gie.2018.04.2330. Epub 2018 Apr 13. Gastrointest Endosc. 2018. PMID: 29660321
Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach.
Peyrin-Biroulet L, Baumgart DC, Armuzzi A, Gionchetti P, Sebastian S, Danese S, Magro F, Higgins S, Yaworksy A, Banderas B, Kachroo S. Peyrin-Biroulet L, et al. Among authors: gionchetti p. Dig Dis. 2018;36(5):346-353. doi: 10.1159/000489845. Epub 2018 Jul 3. Dig Dis. 2018. PMID: 29969780
277 results